Clinical Investigation for the Foldax Tria Mitral Valve- India

NCT06191718 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2024-01-05

No results posted yet for this study

Summary

The purpose of this study is to conduct a clinical investigation of the Foldax Tria Mitral Valve to collect evidence on the device's safety and performance.

Conditions

  • Mitral Valve Disease
  • Mitral Regurgitation
  • Mitral Stenosis
  • Mitral Valve Insufficiency

Interventions

DEVICE

Mitral Valve Replacement

Foldax Mitral Valve Replacement

Sponsors & Collaborators

  • Foldax, Inc

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2024-12-01
Completion
2024-12-01

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06191718 on ClinicalTrials.gov